Treatment for hepatitis C

May 1991
FDA Consumer;May91, Vol. 25 Issue 4, p3
Reports that a genetically engineered product originally licensed in 1986 to treat hairy cell leukemia was approved by the Food and Drug Administration on Feb. 25, 1991, to treat non-A, non-B hepatitis. The product, called alpha interferon, is the first effective treatment against this form of hepatitis which affects an estimated 150,000 Americans each year.


Related Articles

  • FDA approves interferon treatment for hepatitis B.  // Public Health Reports;Nov/Dec92, Vol. 107 Issue 6, p739 

    Announces that the Food and Drug Administration (FDA) has approved recombinant interferon alfa-2b injections as the first treatment for chronic hepatitis B, an infectious liver disease that can lead to cirrhosis, liver cancer, and death. When interferon alfa-2b was first approved; Number of...

  • Biliary access procedure in the management of oriental... Gott, Paul E.; Barcia, Peter J. // American Surgeon;Nov1996, Vol. 62 Issue 11, p930 

    Reviews the treatment of oriental cholangiohepatitis using a combined approach of surgical access to the biliary tree. Information on the treatment used; Definition of oriental cholangiohepatitis; Results of a study conducted on patients with this disease.

  • First hepatitis B treatment.  // FDA Consumer;Oct92, Vol. 26 Issue 8, p3 

    Reports that Intron A (recombinant interferon alfa-2b) was licensed by the Food and Drug Administration last July 13 as the first treatment for chronic hepatitis B, an infectious liver disease that can lead to cirrhosis, liver cancer, and death. How many Americans are carriers of hepatitis B;...

  • Influence of hepatitis G virus infection on the severity of liver disease and response to... Martinot, Michele; Marcellin, Patrick // Annals of Internal Medicine;06/01/97, Vol. 126 Issue 11, p874 

    Assesses the prevalence of hepatitis G virus (HGV) infection, effect of HGV infection on the clinical, virologic, and histologic features of patients with chronic hepatitis C and were treated with interferon-. Influence of HGV on response to interferon- therapy; Study done on 228 patients with...

  • Treatment for hepatitis-B.  // Men's Health;Jan/Feb93, Vol. 8 Issue 1, p25 

    Reports on the approval of a drug called Intron A for treating chronic hepatitis B by the Food and Drug Administration. First effective treatment available.

  • Hope for hepatitis C infections.  // Newsweek;12/11/1989, Vol. 114 Issue 24, p92 

    Discusses two studies recently published in the `New England Journal of Medicine' that suggest administering the antiviral drug alpha interferon can reduce the damage caused by chronic hepatitis C, which attacks the livers of about 150,000 Americans each year.

  • The little drug that really could. Galloway, J.L.; Trimble, J. // U.S. News & World Report;8/13/90, Vol. 109 Issue 7, p14 

    Announces that the drug interferon alfa-2b has proved effective against two types of viral hepatitis, the liver infection that afflicts more than 4 million Americans and is a bigger killer around the world than AIDS. Researchers finding more and more diseases it can fight; Ways hepatitis is...

  • Stirrings. Starr, Cynthia // Drug Topics;7/5/93, Vol. 137 Issue 13, p30 

    Reports on the plan of Gynex Pharmaceutical Inc. to submit a New Drug Application in late 1993 for use of its Oxandrin (oxandrolone). Treatment of patients with alcoholic hepatitis; Reduction in mortality rate after six months of treatment with Oxandrin and a nutritional supplement.

  • Treatment of chronic hepatitis B and hepatitis C with... Molloy, Peter J.; Azzouz, Maher // American Family Physician;10/1/1996, Vol. 54 Issue 5, p1598 

    Focuses on the treatment of chronic hepatitis B and hepatitis C, with the use of interferon alfa-2b, which has been approved by the United States Food and Drug Administration. How the diagnosis of hepatitis B and C, can be acquired; Information on how interferon alpha-2b works; Cost...


Read the Article

Other Topics